Incidence of antibody-drug conjugate-related hepatotoxicity in breast cancer: a systematic review and meta-analysis
{{output}}
Background: Antibody-drug conjugates (ADCs), as a new type of targeted drug, have been widely used in breast cancer patients in recent years. However, while achieving better efficacy, its hepatotoxicity should not be ignored. ... ...
